Histopathological and immunohistochemical study of type 3 complement receptors (CD11b/CD18) in livers and spleens of asymptomatic and symptomatic dogs naturally infected with Leishmania (Leishmania) chagasi

Veterinary Immunology and Immunopathology

Volumn 117, Issue 1-2, 2007, Pages 129-136

  Lima, W G ^a   Oliveira, P S ^a   Caliari, M V ^a   Goncalves R ^a   Michalick, M S M ^a   Melo, M N ^a   Tafuri, W L ^a,a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Canine; CR3 (CD11b CD18) receptors; Liver; Spleen; Visceral leishmaniasis

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENT RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG DISEASE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEISHMANIA CHAGASI; LEISHMANIASIS; LIVER; LIVER GRANULOMA; NONHUMAN; PARASITISM; SPLEEN; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD18; DOG DISEASES; DOGS; IMMUNOHISTOCHEMISTRY; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LIVER DISEASES, PARASITIC; MACROPHAGE-1 ANTIGEN; SPLENIC DISEASES;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA DONOVANI CHAGASI; MURINAE;

EID: 34147154192     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.02.012     Document Type: Article

References (41)

1. Andrade H.M., de Toledo Vde P., Marques M.J., Franca Silva J.C., Tafuri W.L., Mayrink W., and Genaro O. Leishmania (Leishmania) chagasi is not vertically transmitted in dogs. Vet. Parasitol. 103 (2002) 71-81
2. Basu M.K., and Ray M. Macrophage and Leishmania: an unacceptable coexistence. Crit. Rev. Microbiol. 31 (2005) 145-154
3. Burns Jr. J.M., Shreffler W.G., Benson D.R., Ghalib H.W., Badaro R., and Reed S.G. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 775-779
4. Caliari M.V. Princípios de Morfometria Digital vol. 01 (1997), Editora da UFMG, Belo Horizonte p. 150
5. Caliari M.V., de Lana M., Caja R.A., Carneiro C.M., Bahia M.T., Santos C.A., Magalhaes G.A., Sampaio I.B., and Tafuri W.L. Immunohistochemical studies in acute and chronic canine chagasic cardiomyopathy. Virchows Arch. 441 (2002) 69-76
6. Caliari M.V., de La Lana M., Caja R.A., Carneiro C.M., Bahia M.T., Santos C.A., Magalhaes G.A., Cassali G.D., Sampaio I.B.M., and Tafuri W.L. Expression of caCD44, caCD45 and caMHCII in acute and chronic chagasi cardiomyopathy: standartization through KS300 macro assembler. Braz. J. Investig. Pathol. Morphol. Morphom. 1 (2006) 15-23
7. Cervia J.S., Rosen H., and Murray H.W. Effector role of blood monocytes in experimental visceral leishmaniasis. Infect. Immun. 61 (1993) 1330-1333
8. DeSimone D.W., Stepp M.A., Patel R.S., and Hynes R.O. The integrin family of cell surface receptors. Biochem. Soc. Trans. 15 (1987) 789-791
9. el Hag I.A., Hashim F.A., el Toum I.A., Homeida M., el Kalifa M., and el Hassan A.M. Liver morphology and function in visceral leishmaniasis (Kala-azar). J. Clin. Pathol. 47 (1994) 547-551
10. Engwerda C.R., Ato M., and Kaye P.M. Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol. 20 (2004) 524-530
11. Goncalves R., Tafuri W.L., Melo M.N., and Raso P. Chronic interstitial pneumonitis in dogs naturally infected with Leishmania (Leishmania) chagasi: a histopathological and morphometric study. Rev. Inst. Med. Trop. Sao Paulo 45 (2003) 153-158
12. Goncalves R., Vieira E.R., Melo M.N., Gollob K.J., Mosser D.M., and Tafuri W.L. A sensitive flow cytometric methodology for studying the binding of L. chagasi to canine peritoneal macrophages. BMC Infect. Dis. 5 (2005) 39
13. Gonzalez J.L., Rollan E., Novoa C., and Castano M. Structural and ultrastructural hepatic changes in experimental canine leishmaniasis. Histol. Histopathol. 3 (1988) 323-329
14. Handman E., and Bullen D.V. Interaction of Leishmania with the host macrophage. Trends Parasitol. 18 (2002) 332-334
15. Hernandez-Pando R., Bornstein Q.L., Aguilar Leon D., Orozco E.H., Madrigal V.K., and Martinez Cordero E. Inflammatory cytokine production by immunological and foreign body multinucleated giant cells. Immunology 100 (2000) 352-358
16. Houghton R.L., Petrescu M., and Benson D.R. A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy. J. Infect. Dis. 177 (1988) 1339-1344
17. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69 (1992) 11-25
18. Kane M.M., and Mosser D.M. Leishmania parasites and their ploys to disrupt macrophage activation. Curr. Opin. Hematol. 7 (2000) 26-31
19. Kaye P.M., Svensson M., Ato M., Maroof A., Polley R., Stager S., Zubairi S., and Engwerda C.R. The immunopathology of experimental visceral leishmaniasis. Immunol. Rev. 201 (2004) 239-253
20. Leclercq V., Lebastard M., Belkaid Y., Louis J., and Milon G. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. J. Immunol. 157 (1996) 4537-4545
21. Lima W.G., Michalick M.S., de Melo M.N., and Luiz Tafuri W. Canine visceral leishmaniasis: a histopathological study of lymph nodes. Acta Trop. 92 (2004) 43-53
22. Madeira M., Barbosa-Santos E., and Marzochi M. Experimental infection of canine peritoneal macrophages with visceral and dermotropic Leishmania strains. Mem. Inst. Oswaldo Cruz 94 (1999) 645-648
23. Mancianti F., Gramiccia M., Gradoni L., and Pieri S. Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment. Trans. R. Soc. Trop. Med. Hyg. 82 (1988) 566-567
24. Mauricio I.L., Stothard J.R., and Miles M.A. The strange case of Leishmania chagasi. Parasitol. Today 16 (2000) 188-189
25. McElrath M.J., Murray H.W., and Cohn Z.A. The dynamics of granuloma formation in experimental visceral leishmaniasis. J. Exp. Med. 167 (1988) 1927-1937
26. Mosser D.M., and Edelson P.J. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J. Immunol. 135 (1985) 2785-2789
27. Mosser D.M., and Edelson P.J. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature 327 (1987) 329-331
28. Mosser D.M., Springer T.A., and Diamond M.S. Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18). J. Cell. Biol. 116 (1992) 511-520
29. Mosser D.M., and Rosenthal L.A. Leishmania-macrophage interactions: multiple receptors, multiple ligands and diverse cellular responses. Semin. Cell Biol. 4 (1993) 315-322
30. Murray H.W., and Nathan C.F. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 189 (1999) 741-746
31. Murray H.W. Tissue granuloma structure-function in experimental visceral leishmaniasis. Int. J. Exp. Pathol. 82 (2001) 249-267
32. Oliveira G.G., Santoro F., and Sadigursky M. The subclinical form of experimental visceral leishmaniasis in dogs. Mem. Inst. Oswaldo Cruz 88 (1993) 243-248
33. Rosenthal L.A., Sutterwala F.S., Kehrli M.E., and Mosser D.M. Leishmania major-human macrophage interactions: cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion. Infect. Immun. 64 (1996) 2206-2215
34. Rousseau D., Demartino S., Anjuere F., Ferrua B., Fragaki K., Le Fichoux Y., and Kubar J. Sustained parasite burden in the spleen of Leishmania infantum-infected BALB/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge. Eur. Cytokine Netw. 12 (2001) 340-347
35. Sanchez M.A., Diaz N.L., Zerpa O., Negron E., Convit J., and Tapia F.J. Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi. Am. J. Trop. Med. Hyg. 70 (2004) 618-624
36. Sheffield E.A. The granulomatous inflammatory response. J. Pathol. 160 (1990) 1-2
37. Sundar S., and Rai M. Advances in the treatment of leishmaniasis. Curr. Opin. Infect. Dis. 15 (2002) 593-598
38. Tafuri W.L., Barbosa A.J., Michalick M.S., Genaro O., Franca-Silva J.C., Mayrink W., and Nascimento E. Histopathology and immunocytochemical study of type 3 and type 4 complement receptors in the liver and spleen of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi. Rev. Inst. Med. Trop. Sao Paulo 38 (1996) 81-89
39. Tafuri W.L., Santos Rde L., Arantes R.M., Goncalves R., de Melo M.N., and Michalick M.S. An alternative immunohistochemical method for detecting Leishmania amastigotes in paraffin-embedded canine tissues. J. Immunol. Methods 292 (2004) 17-23
40. Teixeira M.J., Teixeira C.R., Andrade B.B., Barral-Netto M., and Barral A. Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol. 22 (2006) 32-40
41. Wilson M.E., Sandor M., Blum A.M., Young B.M., Metwali A., Elliott D., Lynch R.G., and Weinstock J.V. Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J. Immunol. 156 (1996) 2231-2239